Intrinsic value of Mallinckrodt - MNK

Previous Close

$32.42

  Intrinsic Value

$3.75

stock screener

  Rating & Target

str. sell

-88%

  Value-price divergence*

-49%

Previous close

$32.42

 
Intrinsic value

$3.75

 
Up/down potential

-88%

 
Rating

str. sell

 
Value-price divergence*

-49%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of MNK stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 3.2

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -75.45
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  830
  847
  866
  888
  913
  941
  971
  1,004
  1,040
  1,079
  1,120
  1,165
  1,212
  1,262
  1,316
  1,372
  1,433
  1,496
  1,564
  1,635
  1,710
  1,789
  1,873
  1,961
  2,054
  2,151
  2,254
  2,363
  2,477
  2,596
  2,723
Variable operating expenses, $m
 
  566
  571
  577
  583
  590
  598
  606
  616
  626
  636
  298
  310
  323
  336
  351
  366
  382
  400
  418
  437
  457
  479
  501
  525
  550
  576
  604
  633
  664
  696
Fixed operating expenses, $m
 
  499
  512
  524
  538
  551
  565
  579
  593
  608
  623
  639
  655
  671
  688
  705
  723
  741
  760
  779
  798
  818
  838
  859
  881
  903
  925
  949
  972
  997
  1,022
Total operating expenses, $m
  1,037
  1,065
  1,083
  1,101
  1,121
  1,141
  1,163
  1,185
  1,209
  1,234
  1,259
  937
  965
  994
  1,024
  1,056
  1,089
  1,123
  1,160
  1,197
  1,235
  1,275
  1,317
  1,360
  1,406
  1,453
  1,501
  1,553
  1,605
  1,661
  1,718
Operating income, $m
  -207
  -219
  -217
  -213
  -207
  -200
  -191
  -181
  -169
  -155
  -139
  228
  247
  268
  291
  316
  343
  373
  404
  438
  475
  514
  556
  600
  648
  699
  753
  810
  871
  936
  1,005
EBITDA, $m
  -4
  470
  479
  492
  507
  526
  547
  570
  597
  626
  658
  694
  732
  773
  817
  865
  916
  971
  1,029
  1,092
  1,158
  1,229
  1,304
  1,384
  1,469
  1,559
  1,654
  1,755
  1,861
  1,974
  2,094
Interest expense (income), $m
  0
  206
  212
  220
  229
  239
  251
  264
  278
  293
  309
  326
  344
  364
  385
  408
  431
  457
  483
  511
  541
  572
  606
  641
  677
  716
  757
  800
  845
  893
  943
Earnings before tax, $m
  -299
  -425
  -428
  -433
  -436
  -440
  -442
  -445
  -446
  -447
  -448
  -98
  -97
  -96
  -94
  -91
  -88
  -84
  -79
  -73
  -66
  -59
  -50
  -40
  -29
  -18
  -4
  10
  26
  43
  62
Tax expense, $m
  -122
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  3
  7
  12
  17
Net income, $m
  -153
  -425
  -428
  -433
  -436
  -440
  -442
  -445
  -446
  -447
  -448
  -98
  -97
  -96
  -94
  -91
  -88
  -84
  -79
  -73
  -66
  -59
  -50
  -40
  -29
  -18
  -4
  7
  19
  32
  45

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  342
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  15,206
  15,118
  15,466
  15,863
  16,309
  16,804
  17,346
  17,937
  18,576
  19,265
  20,005
  20,796
  21,640
  22,538
  23,493
  24,507
  25,581
  26,718
  27,920
  29,190
  30,531
  31,947
  33,439
  35,012
  36,670
  38,415
  40,253
  42,188
  44,224
  46,366
  48,618
Adjusted assets (=assets-cash), $m
  14,864
  15,118
  15,466
  15,863
  16,309
  16,804
  17,346
  17,937
  18,576
  19,265
  20,005
  20,796
  21,640
  22,538
  23,493
  24,507
  25,581
  26,718
  27,920
  29,190
  30,531
  31,947
  33,439
  35,012
  36,670
  38,415
  40,253
  42,188
  44,224
  46,366
  48,618
Revenue / Adjusted assets
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
  0.056
Average production assets, $m
  9,954
  10,153
  10,387
  10,654
  10,953
  11,286
  11,650
  12,047
  12,476
  12,939
  13,435
  13,967
  14,533
  15,137
  15,778
  16,459
  17,180
  17,944
  18,751
  19,604
  20,505
  21,456
  22,458
  23,514
  24,628
  25,800
  27,035
  28,334
  29,701
  31,140
  32,653
Working capital, $m
  260
  193
  197
  203
  208
  215
  221
  229
  237
  246
  255
  266
  276
  288
  300
  313
  327
  341
  356
  373
  390
  408
  427
  447
  468
  490
  514
  539
  565
  592
  621
Total debt, $m
  6,152
  6,044
  6,276
  6,542
  6,841
  7,172
  7,535
  7,930
  8,358
  8,819
  9,313
  9,842
  10,407
  11,008
  11,647
  12,325
  13,044
  13,804
  14,608
  15,458
  16,355
  17,302
  18,301
  19,353
  20,462
  21,630
  22,860
  24,154
  25,516
  26,949
  28,456
Total liabilities, $m
  10,222
  10,114
  10,346
  10,612
  10,911
  11,242
  11,605
  12,000
  12,428
  12,889
  13,383
  13,912
  14,477
  15,078
  15,717
  16,395
  17,114
  17,874
  18,678
  19,528
  20,425
  21,372
  22,371
  23,423
  24,532
  25,700
  26,930
  28,224
  29,586
  31,019
  32,526
Total equity, $m
  4,984
  5,004
  5,119
  5,251
  5,398
  5,562
  5,742
  5,937
  6,149
  6,377
  6,622
  6,883
  7,163
  7,460
  7,776
  8,112
  8,467
  8,844
  9,241
  9,662
  10,106
  10,574
  11,068
  11,589
  12,138
  12,716
  13,324
  13,964
  14,638
  15,347
  16,093
Total liabilities and equity, $m
  15,206
  15,118
  15,465
  15,863
  16,309
  16,804
  17,347
  17,937
  18,577
  19,266
  20,005
  20,795
  21,640
  22,538
  23,493
  24,507
  25,581
  26,718
  27,919
  29,190
  30,531
  31,946
  33,439
  35,012
  36,670
  38,416
  40,254
  42,188
  44,224
  46,366
  48,619
Debt-to-equity ratio
  1.234
  1.210
  1.230
  1.250
  1.270
  1.290
  1.310
  1.340
  1.360
  1.380
  1.410
  1.430
  1.450
  1.480
  1.500
  1.520
  1.540
  1.560
  1.580
  1.600
  1.620
  1.640
  1.650
  1.670
  1.690
  1.700
  1.720
  1.730
  1.740
  1.760
  1.770
Adjusted equity ratio
  0.312
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331
  0.331

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -153
  -425
  -428
  -433
  -436
  -440
  -442
  -445
  -446
  -447
  -448
  -98
  -97
  -96
  -94
  -91
  -88
  -84
  -79
  -73
  -66
  -59
  -50
  -40
  -29
  -18
  -4
  7
  19
  32
  45
Depreciation, amort., depletion, $m
  203
  688
  696
  705
  715
  726
  738
  751
  766
  781
  798
  466
  484
  505
  526
  549
  573
  598
  625
  653
  684
  715
  749
  784
  821
  860
  901
  944
  990
  1,038
  1,088
Funds from operations, $m
  321
  264
  268
  272
  278
  286
  296
  307
  319
  334
  350
  368
  387
  409
  432
  457
  485
  514
  546
  581
  617
  657
  699
  744
  791
  842
  897
  952
  1,009
  1,070
  1,134
Change in working capital, $m
  125
  4
  4
  5
  6
  6
  7
  8
  8
  9
  9
  10
  11
  11
  12
  13
  14
  15
  15
  16
  17
  18
  19
  20
  21
  22
  23
  25
  26
  27
  29
Cash from operations, $m
  196
  260
  263
  267
  273
  280
  289
  299
  311
  325
  340
  357
  376
  397
  420
  444
  471
  500
  531
  564
  600
  639
  680
  723
  770
  820
  873
  927
  983
  1,042
  1,105
Maintenance CAPEX, $m
  0
  -332
  -338
  -346
  -355
  -365
  -376
  -388
  -402
  -416
  -431
  -448
  -466
  -484
  -505
  -526
  -549
  -573
  -598
  -625
  -653
  -684
  -715
  -749
  -784
  -821
  -860
  -901
  -944
  -990
  -1,038
New CAPEX, $m
  -65
  -199
  -234
  -267
  -300
  -332
  -364
  -397
  -429
  -463
  -497
  -531
  -567
  -604
  -641
  -681
  -721
  -764
  -807
  -853
  -901
  -950
  -1,002
  -1,057
  -1,113
  -1,172
  -1,234
  -1,299
  -1,367
  -1,438
  -1,513
Cash from investing activities, $m
  -77
  -531
  -572
  -613
  -655
  -697
  -740
  -785
  -831
  -879
  -928
  -979
  -1,033
  -1,088
  -1,146
  -1,207
  -1,270
  -1,337
  -1,405
  -1,478
  -1,554
  -1,634
  -1,717
  -1,806
  -1,897
  -1,993
  -2,094
  -2,200
  -2,311
  -2,428
  -2,551
Free cash flow, $m
  119
  -271
  -309
  -346
  -382
  -417
  -452
  -486
  -520
  -554
  -588
  -622
  -656
  -691
  -726
  -762
  -799
  -836
  -875
  -914
  -954
  -995
  -1,038
  -1,082
  -1,127
  -1,173
  -1,221
  -1,273
  -1,329
  -1,386
  -1,446
Issuance/(repayment) of debt, $m
  103
  163
  233
  266
  299
  331
  363
  395
  428
  461
  495
  529
  565
  601
  639
  678
  718
  761
  804
  850
  897
  947
  998
  1,052
  1,109
  1,168
  1,230
  1,294
  1,362
  1,433
  1,507
Issuance/(repurchase) of shares, $m
  -158
  516
  543
  564
  584
  603
  622
  640
  658
  675
  693
  360
  377
  393
  410
  427
  443
  460
  477
  493
  510
  527
  544
  561
  578
  595
  613
  633
  655
  677
  700
Cash from financing (excl. dividends), $m  
  -54
  679
  776
  830
  883
  934
  985
  1,035
  1,086
  1,136
  1,188
  889
  942
  994
  1,049
  1,105
  1,161
  1,221
  1,281
  1,343
  1,407
  1,474
  1,542
  1,613
  1,687
  1,763
  1,843
  1,927
  2,017
  2,110
  2,207
Total cash flow (excl. dividends), $m
  62
  407
  467
  484
  501
  517
  533
  549
  566
  583
  600
  267
  285
  304
  323
  343
  363
  384
  406
  429
  453
  478
  504
  532
  560
  590
  621
  654
  688
  724
  761
Retained Cash Flow (-), $m
  287
  -516
  -543
  -564
  -584
  -603
  -622
  -640
  -658
  -675
  -693
  -360
  -377
  -393
  -410
  -427
  -443
  -460
  -477
  -493
  -510
  -527
  -544
  -561
  -578
  -595
  -613
  -640
  -674
  -709
  -746
Prev. year cash balance distribution, $m
 
  71
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  -37
  -76
  -80
  -83
  -86
  -89
  -91
  -92
  -93
  -93
  -92
  -91
  -90
  -87
  -84
  -80
  -76
  -70
  -64
  -57
  -49
  -39
  -29
  -18
  -5
  9
  14
  14
  15
  16
Discount rate, %
 
  9.90
  10.40
  10.91
  11.46
  12.03
  12.64
  13.27
  13.93
  14.63
  15.36
  16.13
  16.93
  17.78
  18.67
  19.60
  20.58
  21.61
  22.69
  23.83
  25.02
  26.27
  27.58
  28.96
  30.41
  31.93
  33.52
  35.20
  36.96
  38.81
  40.75
PV of cash for distribution, $m
 
  -34
  -62
  -59
  -54
  -49
  -44
  -38
  -32
  -27
  -22
  -18
  -14
  -11
  -8
  -6
  -4
  -3
  -2
  -1
  -1
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  87.0
  75.3
  65.0
  56.1
  48.4
  41.7
  36.0
  31.1
  26.9
  23.3
  21.6
  20.0
  18.6
  17.2
  16.0
  14.8
  13.7
  12.8
  11.8
  11.0
  10.3
  9.6
  8.9
  8.3
  7.8
  7.3
  6.8
  6.4
  6.0
  5.6

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

FINANCIAL RATIOS  of  Mallinckrodt (MNK)

Valuation Ratios
P/E Ratio -22.2
Price to Sales 4.1
Price to Book 0.7
Price to Tangible Book
Price to Cash Flow 17.3
Price to Free Cash Flow 25.9
Growth Rates
Sales Growth Rate -75.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -64.5%
Cap. Spend. - 3 Yr. Gr. Rate -12.7%
Financial Strength
Quick Ratio 1
Current Ratio 0.2
LT Debt to Equity 118%
Total Debt to Equity 123.4%
Interest Coverage 0
Management Effectiveness
Return On Assets -1%
Ret/ On Assets - 3 Yr. Avg. 4.2%
Return On Total Capital -1.4%
Ret/ On T. Cap. - 3 Yr. Avg. 2.5%
Return On Equity -3%
Return On Equity - 3 Yr. Avg. 5.2%
Asset Turnover 0.1
Profitability Ratios
Gross Margin 53.7%
Gross Margin - 3 Yr. Avg. 54.8%
EBITDA Margin -11.6%
EBITDA Margin - 3 Yr. Avg. 21.1%
Operating Margin -24.9%
Oper. Margin - 3 Yr. Avg. 1.8%
Pre-Tax Margin -36%
Pre-Tax Margin - 3 Yr. Avg. -8.5%
Net Profit Margin -18.4%
Net Profit Margin - 3 Yr. Avg. 3.9%
Effective Tax Rate 40.8%
Eff/ Tax Rate - 3 Yr. Avg. -63.5%
Payout Ratio 0%

MNK stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MNK stock intrinsic value calculation we used $830 million for the last fiscal year's total revenue generated by Mallinckrodt. The default revenue input number comes from 2016 income statement of Mallinckrodt. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MNK stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 9.9%, whose default value for MNK is calculated based on our internal credit rating of Mallinckrodt, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Mallinckrodt.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MNK stock the variable cost ratio is equal to 67.7%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $487 million in the base year in the intrinsic value calculation for MNK stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Mallinckrodt.

Corporate tax rate of 27% is the nominal tax rate for Mallinckrodt. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MNK stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MNK are equal to 1199.3%.

Life of production assets of 66.8 years is the average useful life of capital assets used in Mallinckrodt operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MNK is equal to 22.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $4984 million for Mallinckrodt - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 99.205 million for Mallinckrodt is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Mallinckrodt at the current share price and the inputted number of shares is $3.2 billion.

RELATED COMPANIES Price Int.Val. Rating
LNTH Lantheus Holdi 18.25 0.75  str.sell
PFE Pfizer 36.42 28.30  hold
NVS Novartis ADR 85.74 35.84  str.sell
DEPO DepoMed 5.39 1.01  str.sell
JNJ Johnson&Johnso 142.40 96.55  sell
TEVA Teva Pharmaceu 14.90 57.61  str.buy
GE General Electr 23.83 17.24  sell

COMPANY NEWS

▶ Fighting the Toxic Nightmare Next Door   [05:00AM  Bloomberg]
▶ [$$] Mallinckrodt Closes InfaCare Acquisition   [Sep-26-17 07:54PM  The Wall Street Journal]
▶ Why Mallinckrodt Got Crushed   [Sep-05-17 04:51PM  Barrons.com]
▶ Morningstar Runs the Numbers   [Aug-19-17 06:00AM  Morningstar]
▶ Mallinckrodt Was the S&P 500s Biggest Loser on August 8   [Aug-09-17 10:39AM  Market Realist]
▶ Mallinckrodt beats 2Q profit forecasts   [Aug-08-17 09:51PM  Associated Press]
▶ Multnomah County seeks $250M from Purdue, other opioid manufacturers   [Aug-07-17 05:06PM  American City Business Journals]
▶ Teva and 3D Systems slide while Kellogg and Tesla jump   [Aug-03-17 04:31PM  Associated Press]
▶ McCaskill expands opioid probe to include Mallinckrodt   [Jul-28-17 08:45AM  American City Business Journals]
▶ Mallinckrodt triples its spending on lobbying   [Jul-21-17 08:15AM  American City Business Journals]
▶ The Highs and Lows for Fallen S&P 500 Stocks   [Jul-20-17 03:05PM  The Wall Street Journal]
▶ Valeant Unloads Yet Another Unit   [Jul-17-17 11:30AM  Barrons.com]
▶ ETFs with exposure to Mallinckrodt Plc : July 14, 2017   [Jul-14-17 03:37PM  Capital Cube]
▶ After-hours buzz: AMG, MNK & more   [Jul-12-17 05:40PM  CNBC]
▶ L Brands Was the S&P 500s Top Loser on July 6   [Jul-07-17 11:36AM  Market Realist]
Financial statements of MNK
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.